• Clinic, research and teaching: Prof. Marcacci in an interview
• Active surveillance in bladder cancer: new study confirms validity
• Severe heart attack and research: the role of new generation anticoagulants
• Immunity and tumors: researcher Martina Molgora receives an award
• Combination of PET/CT for primary diagnosis of prostate cancer: promising results from a Humanitas study
• Advanced hepatocarcinoma: positive results from the Cabozantinib study, in which Humanitas also took part
• Seminal fluid biopsy for prostate cancer diagnosis: promising first results from a Humanitas study
• Sepsis: A protein predicts the prognosis and risk of mortality. The results of a study in which Humanitas also took part
• ALEX, the new test for molecular allergological diagnosis: a published study by Humanitas specialists
• Advances in Research in Oncology and Hematology: live Facebook stream with Prof. Santoro, Prof. Simonelli and Dr. Rossi
• Hepatocarcinoma: the results of the Humanitas study published in The Lancet Oncology
• New diagnostic techniques in Gastroenterology: Professor Repici’s intervention at Wired Health
• The Image of Artificial Intelligence: Professor Chiti’s Speech at Wired Health
• The super test that maps allergies
• “Bersaglio mobile”, Prof. Mantovani presents his book on Rai Radio uno
• Cancer and Research: “Moving Target”, the new book by Prof. Mantovani
• Ulcerative colitis, the first results of a new study with apremilast presented in Vienna by professor Danese
• Blood tumors and genome studies: in Humanitas a diagnostic test from a personalized medical point of view
• Severe Infarction: A New Therapeutic Opportunity from New Generation Anticoagulant Drugs
• The role of Research and future prospects: Prof. Mantovani on Rai Radio 1
• A new European study coordinated by Humanitas for the treatment of ALS is launched